“Virtual” biotech companies typically consist of one or two Kool-Aid-drinking founder-executives and some drug candidates that no one else wanted. The track record of these companies in getting drugs approved for marketing or getting them partnered on favorable economic terms is so dismal that you’d probably have better odds betting on Estonia to win the most medals of any country at the next Olympics.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.